Cobe Labs
This article was originally published in The Gray Sheet
Executive Summary
Gambro unit receives FDA clearance for the Trima automated blood component collection system, the firm reports Feb. 11. An alternative to whole blood collections, the system is the "first device to allow blood centers to collect combinations of red blood cells, platelets, and plasma simultaneously from a single blood donor," the company says. By collecting the blood products from the same donor, the Trima system yields "more transfusable products per donation than conventional whole blood collection"